A Rare Hematopoietic Stem Cell‐Derived Megakaryocyte Progenitor Accumulates via Enhanced Survival and Contributes to Exacerbated Thrombopoiesis Upon Aging

Distinct routes of cellular production from hematopoietic stem cells (HSCs) have defined our current view of hematopoiesis. Recently, we and others have challenged classical views of platelet generation, demonstrating that megakaryocyte progenitors (MkPs) and ultimately platelets can be specified via an alternate and additive route of HSC-direct specification specifically during aging. This "shortcut" pathway generates hyperactive platelets likely to contribute to age-related platelet-mediated morbidities. Here, we used single-cell RNA/CITEseq to demonstrate that these age-unique, noncanonical (nc)MkPs can be prospectively defined and experimentally isolated from wild-type mice. Surprisingly, this revealed that a rare population of ncMkPs also exists in young mice. Young and aged ncMkPs are functionally distinct from each other and from their canonical (c)MkP counterparts, with aged ncMkPs paradoxically and uniquely exhibiting enhanced survival and platelet generation capacity. We further demonstrate that aged HSCs generate significantly more ncMkPs than their younger counterparts, yet this is accomplished without strict clonal restriction. Together, these findings reveal significant phenotypic, functional, and aging-dependent heterogeneity among the MkP pool and uncover unique features of megakaryopoiesis throughout life, potentially offering cellular and molecular targets for the mitigation of age-related adverse thrombotic events.

Authors

Institutions

Publication Details

Journal
Aging Cell
Published
2025-09-23
DOI
https://doi.org/10.1111/acel.70221
Citations
1
Primary Topic
Platelet Disorders and Treatments
Type
article
Field-Weighted Citation Impact
1.77
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Rare Hematopoietic Stem Cell‐Derived Megakaryocyte Progenitor Accumulates via Enhanced Survival and Contributes to Exacerbated Thrombopoiesis Upon Aging

Alessandra Rodriguez y Baena, E. Camilla Forsberg, Vanessa D. Jönsson, Lydia Mok et al.
1 citations
Aging Cell
Platelet Disorders and Treatments
1.77
article

A Rare Hematopoietic Stem Cell‐Derived Megakaryocyte Progenitor Accumulates via Enhanced Survival and Contributes to Exacerbated Thrombopoiesis Upon Aging

Alessandra Rodriguez y Baena, E. Camilla Forsberg, Vanessa D. Jönsson, Lydia Mok, Stephanie Smith‐Berdan, Paloma Medina, Bryce Manso, Saran Chattopadhyaya, Marcel G. E. Rommel, Angela Deguzman, Elmira Bachinsky, Sarah Beth Avila, Jenna Myers, Connor Van Voorhis
article en
1 citations

Abstract

Distinct routes of cellular production from hematopoietic stem cells (HSCs) have defined our current view of hematopoiesis. Recently, we and others have challenged classical views of platelet generation, demonstrating that megakaryocyte progenitors (MkPs) and ultimately platelets can be specified via an alternate and additive route of HSC-direct specification specifically during aging. This "shortcut" pathway generates hyperactive platelets likely to contribute to age-related platelet-mediated morbidities. Here, we used single-cell RNA/CITEseq to demonstrate that these age-unique, noncanonical (nc)MkPs can be prospectively defined and experimentally isolated from wild-type mice. Surprisingly, this revealed that a rare population of ncMkPs also exists in young mice. Young and aged ncMkPs are functionally distinct from each other and from their canonical (c)MkP counterparts, with aged ncMkPs paradoxically and uniquely exhibiting enhanced survival and platelet generation capacity. We further demonstrate that aged HSCs generate significantly more ncMkPs than their younger counterparts, yet this is accomplished without strict clonal restriction. Together, these findings reveal significant phenotypic, functional, and aging-dependent heterogeneity among the MkP pool and uncover unique features of megakaryopoiesis throughout life, potentially offering cellular and molecular targets for the mitigation of age-related adverse thrombotic events.

Aging CellVol. 24(11)
University of California, Santa Cruz (US)
Openalex Percentile: Top 12%
Platelet Disorders and Treatments
1.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.